What’s Driving the In Vitro Diagnostics Industry?--The Road to 2020 and Beyond: Alternative Scenarios of the Future IVD Market--Business-as-Usual, Economic Austerity, Technological Breakthroughs 2017-2021
This new report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead. The study objectives include: How will the future reimbursement changes affect individual market segments? Will the industry consolidate, decentralize, or undergo a bimodal transformation? What will be the impact on purchasing influences, marketing strategies, joint ventures, mergers, licensing, import and export? How will the future technological advances affect the major market segment? Which companies will enter the market and which will not survive?
These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.
Contains 255 pages and 32 tables
- To identify and evaluate emerging markets and technologies that may present unexpected threats or offer opportunities.
- To identify key strategic decisions that will have to be made in the future.
- To enhance corporate ability to develop realistic contingency plans.
- To prepare executives to accommodate radically different operating climates and reduce surprises.
- To challenge accepted perceptions of the future diagnostics market.
These and other key issues facing the decision-makers are explored in this thought-provoking and multi-faceted portrait of the three possible futures and their strategic implication. We would be glad to answer any questions you might have regarding this informative, comprehensive and insightful market research and technology assessment report, and look forward to your subscription.
Contains 255 pages and 32 tables
1. INTRODUCTION
2. EXECUTIVE SUMMARY
A. BUSINESS AS USUAL SCENARIO
B. ECONOMIC AUSTERITY SCENARIO
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
3. CONCLUSIONS AND RECOMMENDATIONS
4.THE SCENARIOS
A. BUSINESS AS USUAL SCENARIO
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPOs
HMOs
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
Chronic Illnesses
Disease Incidence
Susceptibility to Iatrogenesis
Multiple Illness Cases
l. Laboratory Regulations
m. The FDA Reform
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. GOVERNMENT REGULATIONS
b. Centralized Testing
Hospitals
Commercial Laboratories
Blood Banks
Public Health Laboratories
c. Decentralized Testing
Personal Testing
Physician Offices/Group Practices Ancillary Hospital Locations
ERs
ORs
ICUs/CCUs
Cancer Clinics
Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers 3. Strategic Implications
a. Testing Patterns
Test Utilization
Pre Admission Testing
Inpatient Testing
Outpatient Testing
4. MARKET SEGMENTS
a. Chemistry and Immunoassay INTRODUCTION
Future Situation
b. Microbiology and Serology
INTRODUCTION
Future Situation
c. Hematology and Flow Cytometry
INTRODUCTION
Future Situation
d. Histology and Cytology
INTRODUCTION
Future Situation
e. Coagulation
INTRODUCTION
Future Situation
f. Urinalysis
INTRODUCTION
Future Situation
g. Blood Banking
INTRODUCTION
Future Situation
5.TECHNOLOGIES
a. Genomics
INTRODUCTION
Future Situation
b. Proteomics
INTRODUCTION
Future Situation
c. DNA Probes
INTRODUCTION
Future Situation
d. Biochips/Microarrays
INTRODUCTION
Future Situation
e. Monoclonal Antibodies
INTRODUCTION
Future Situation
f. Solid Phase Chemistry
INTRODUCTION
Future Situation
g. Biosensors
INTRODUCTION
Future Situation
h. Automation and Robotics
INTRODUCTION
Future Situation
i. Computer Aided Diagnosis
INTRODUCTION
Future Situation
6.THE NEW MARKETPLACE
a. Purchasing Influences
b. Marketing Strategies
c. Joint Ventures, Mergers and Licensing
d. Import Export
e. Potential Market Entrants
f. Who May Not Survive?
B. ECONOMIC AUSTERITY SCENARIO
1. BUSINESS ENVIRONMENT
a. Socio olitical Climate
Cost Consciousness
Government Actions
Three Tier System
Health Rationing
Voucher System
Health IRA
b. Hospital Closures
c. Hospital Utilization
d. Hospital Reorganization
e. Physician Regulations
f. Wellness Programs
g. Corporate Responses
h. Academic Research
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. TEST UTILIZATION
Ordering Practices
Documentation
Recertification
b.Technology Regulations
c. New Laboratory Ventures
d. Computers
e. Industrial Medicine
f. Insurance Companies
g. Test Volume and Market Size
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre Admission Testing
Inpatient Testing
Outpatient Testing
b. Market Segments
Chemistry and Immunoassay Microbiology and Serology
Hematology and Flow Cytometry
Histology and Cytology
Coagulation
Urinalysis
Blood Banking
c.Technologies
Genomics
Proteomics
DNA Probes
Biochips/Microarrays
Monoclonal Antibodies and Immunoassays
Automation and Robotics
Solid Phase Chemistry
Biosensors
Computer Aided Diagnosis
d.The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Ventures, Mergers and Licensing
Import Export
Potential Market Entrants
Who May Not Survive?
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
1. BUSINESS ENVIRONMENT
a. Political/Regulatory Climate
b. R & D Funding
c. Industry Government Relationship
d. Industry University Ventures
e.Technological Environment
f. Testing Decentralization
g. Health Care Expenditures
h. Physician Population
i. Hospital Indicators
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. OVERVIEW
b. Genomics
c. Proteomics
d. DNA and RNA Probes
e. Biochips/Microarrays
f. Monoclonal Antibodies
g. Immunoassays
h. Information Technology
i. Laboratory Automation and Robotics
j. Solid Phase Chemistry
k. Biosensors
l. Holography
m. Pharmaceuticals
3. STRATEGIC IMPLICATIONS
a.Testing Patterns
Pre Admission Testing
Inpatient Testing
Outpatient Testing
Test Volume and Market Size
b. Market Segments
Chemistry and Immunoassay Microbiology and Serology
Hematology and Flow Cytometry
Histology and Cytology
Coagulation
Urinalysis
Blood Banking
c.The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Ventures, Mergers and Licensing
Import Export
Potential Market Entrants
Who May Not Survive?
5.APPENDICES: METHODOLOGY
A.The Delphi
B. Cross Impact Analysis
C. Substitution Modeling
Table of Contents
Executive Summary Table I: Business - Usual
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table II: Economic Austerity
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table III: Technological
Breakthroughs Scenario, Growth Areas in
Clinical Laboratory Testing
Executive Summary Table IV: Market Size by Location
Executive Summary Table V: Market Size by Laboratory
Discipline
Table 1: Business - Usual Scenario, Health
Care Costs by Expenditure Type
Table 2: Business - Usual Scenario, HM and PPO
Enrollment
Table 3: Business - Usual Scenario, Selected
Hospital Statistics
Table 4: Business - Usual Scenario, Total Population and Physician Demographics
Table 5: Business - Usual Scenario, Test Volume by Location
Table 6: Business - Usual Scenario, Test Distribution by Location
Table 7: Business - Usual Scenario, Market Size by Location
Table 8: Business - Usual Scenario, Typical
Pre Admission Tests
Table 9: Business - Usual Scenario, Test Volume by Laboratory Discipline
Table 10: Business - Usual Scenario, Market Size by Laboratory Discipline
Table 11: Economic Austerity Scenario, Selected
Hospital Statistics
Table 12: Economic Austerity Scenario, HM and PP Enrollment
Table 13: Economic Austerity Scenario, Total Population and Physician Demographics
Table 14: Economic Austerity Scenario, Major
Categories of Overutilized Tests
Table 15: Economic Austerity Scenario, Test Volume by Location
Table 16: Economic Austerity Scenario, Test
Distribution by Location
Table 17: Economic Austerity Scenario, Market Size by Location
Table 18: Economic Austerity Scenario, Timing
Requirements for Selected Laboratory Tests
Table 19: Economic Austerity Scenario, Test Volume by Laboratory Discipline
Table 20: Economic Austerity Scenario, Market Size by Laboratory Discipline
Table 21: Technological Breakthroughs Scenario, HM and PP Enrollment
Table 22: Technological Breakthroughs Scenario, Total Population and Physician Demographics
Table 23: Technological Breakthroughs Scenario, Selected Hospital Statistics
Table 24: Technological Breakthroughs Scenario, Test Volume by Location
Table 25: Technological Breakthroughs Scenario, Test Distribution by Location
Table 26: Technological Breakthroughs Scenario, Market Size by Location
Table 27: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
Table 28: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline
2. EXECUTIVE SUMMARY
A. BUSINESS AS USUAL SCENARIO
B. ECONOMIC AUSTERITY SCENARIO
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
3. CONCLUSIONS AND RECOMMENDATIONS
4.THE SCENARIOS
A. BUSINESS AS USUAL SCENARIO
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPOs
HMOs
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
Chronic Illnesses
Disease Incidence
Susceptibility to Iatrogenesis
Multiple Illness Cases
l. Laboratory Regulations
m. The FDA Reform
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. GOVERNMENT REGULATIONS
b. Centralized Testing
Hospitals
Commercial Laboratories
Blood Banks
Public Health Laboratories
c. Decentralized Testing
Personal Testing
Physician Offices/Group Practices Ancillary Hospital Locations
ERs
ORs
ICUs/CCUs
Cancer Clinics
Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers 3. Strategic Implications
a. Testing Patterns
Test Utilization
Pre Admission Testing
Inpatient Testing
Outpatient Testing
4. MARKET SEGMENTS
a. Chemistry and Immunoassay INTRODUCTION
Future Situation
b. Microbiology and Serology
INTRODUCTION
Future Situation
c. Hematology and Flow Cytometry
INTRODUCTION
Future Situation
d. Histology and Cytology
INTRODUCTION
Future Situation
e. Coagulation
INTRODUCTION
Future Situation
f. Urinalysis
INTRODUCTION
Future Situation
g. Blood Banking
INTRODUCTION
Future Situation
5.TECHNOLOGIES
a. Genomics
INTRODUCTION
Future Situation
b. Proteomics
INTRODUCTION
Future Situation
c. DNA Probes
INTRODUCTION
Future Situation
d. Biochips/Microarrays
INTRODUCTION
Future Situation
e. Monoclonal Antibodies
INTRODUCTION
Future Situation
f. Solid Phase Chemistry
INTRODUCTION
Future Situation
g. Biosensors
INTRODUCTION
Future Situation
h. Automation and Robotics
INTRODUCTION
Future Situation
i. Computer Aided Diagnosis
INTRODUCTION
Future Situation
6.THE NEW MARKETPLACE
a. Purchasing Influences
b. Marketing Strategies
c. Joint Ventures, Mergers and Licensing
d. Import Export
e. Potential Market Entrants
f. Who May Not Survive?
B. ECONOMIC AUSTERITY SCENARIO
1. BUSINESS ENVIRONMENT
a. Socio olitical Climate
Cost Consciousness
Government Actions
Three Tier System
Health Rationing
Voucher System
Health IRA
b. Hospital Closures
c. Hospital Utilization
d. Hospital Reorganization
e. Physician Regulations
f. Wellness Programs
g. Corporate Responses
h. Academic Research
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. TEST UTILIZATION
Ordering Practices
Documentation
Recertification
b.Technology Regulations
c. New Laboratory Ventures
d. Computers
e. Industrial Medicine
f. Insurance Companies
g. Test Volume and Market Size
3. STRATEGIC IMPLICATIONS
a. Testing Patterns
Pre Admission Testing
Inpatient Testing
Outpatient Testing
b. Market Segments
Chemistry and Immunoassay Microbiology and Serology
Hematology and Flow Cytometry
Histology and Cytology
Coagulation
Urinalysis
Blood Banking
c.Technologies
Genomics
Proteomics
DNA Probes
Biochips/Microarrays
Monoclonal Antibodies and Immunoassays
Automation and Robotics
Solid Phase Chemistry
Biosensors
Computer Aided Diagnosis
d.The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Ventures, Mergers and Licensing
Import Export
Potential Market Entrants
Who May Not Survive?
C.TECHNOLOGICAL BREAKTHROUGHS SCENARIO
1. BUSINESS ENVIRONMENT
a. Political/Regulatory Climate
b. R & D Funding
c. Industry Government Relationship
d. Industry University Ventures
e.Technological Environment
f. Testing Decentralization
g. Health Care Expenditures
h. Physician Population
i. Hospital Indicators
2. OUTLOOK FOR THE IN VITR DIAGNOSTICS MARKET A. OVERVIEW
b. Genomics
c. Proteomics
d. DNA and RNA Probes
e. Biochips/Microarrays
f. Monoclonal Antibodies
g. Immunoassays
h. Information Technology
i. Laboratory Automation and Robotics
j. Solid Phase Chemistry
k. Biosensors
l. Holography
m. Pharmaceuticals
3. STRATEGIC IMPLICATIONS
a.Testing Patterns
Pre Admission Testing
Inpatient Testing
Outpatient Testing
Test Volume and Market Size
b. Market Segments
Chemistry and Immunoassay Microbiology and Serology
Hematology and Flow Cytometry
Histology and Cytology
Coagulation
Urinalysis
Blood Banking
c.The New Marketplace
Purchasing Influences
Marketing Strategies
Joint Ventures, Mergers and Licensing
Import Export
Potential Market Entrants
Who May Not Survive?
5.APPENDICES: METHODOLOGY
A.The Delphi
B. Cross Impact Analysis
C. Substitution Modeling
Table of Contents
Executive Summary Table I: Business - Usual
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table II: Economic Austerity
Scenario, Growth Areas in Clinical Laboratory
Testing
Executive Summary Table III: Technological
Breakthroughs Scenario, Growth Areas in
Clinical Laboratory Testing
Executive Summary Table IV: Market Size by Location
Executive Summary Table V: Market Size by Laboratory
Discipline
Table 1: Business - Usual Scenario, Health
Care Costs by Expenditure Type
Table 2: Business - Usual Scenario, HM and PPO
Enrollment
Table 3: Business - Usual Scenario, Selected
Hospital Statistics
Table 4: Business - Usual Scenario, Total Population and Physician Demographics
Table 5: Business - Usual Scenario, Test Volume by Location
Table 6: Business - Usual Scenario, Test Distribution by Location
Table 7: Business - Usual Scenario, Market Size by Location
Table 8: Business - Usual Scenario, Typical
Pre Admission Tests
Table 9: Business - Usual Scenario, Test Volume by Laboratory Discipline
Table 10: Business - Usual Scenario, Market Size by Laboratory Discipline
Table 11: Economic Austerity Scenario, Selected
Hospital Statistics
Table 12: Economic Austerity Scenario, HM and PP Enrollment
Table 13: Economic Austerity Scenario, Total Population and Physician Demographics
Table 14: Economic Austerity Scenario, Major
Categories of Overutilized Tests
Table 15: Economic Austerity Scenario, Test Volume by Location
Table 16: Economic Austerity Scenario, Test
Distribution by Location
Table 17: Economic Austerity Scenario, Market Size by Location
Table 18: Economic Austerity Scenario, Timing
Requirements for Selected Laboratory Tests
Table 19: Economic Austerity Scenario, Test Volume by Laboratory Discipline
Table 20: Economic Austerity Scenario, Market Size by Laboratory Discipline
Table 21: Technological Breakthroughs Scenario, HM and PP Enrollment
Table 22: Technological Breakthroughs Scenario, Total Population and Physician Demographics
Table 23: Technological Breakthroughs Scenario, Selected Hospital Statistics
Table 24: Technological Breakthroughs Scenario, Test Volume by Location
Table 25: Technological Breakthroughs Scenario, Test Distribution by Location
Table 26: Technological Breakthroughs Scenario, Market Size by Location
Table 27: Technological Breakthroughs Scenario, Test Volume by Laboratory Discipline
Table 28: Technological Breakthroughs Scenario, Market Size by Laboratory Discipline
